Narrow search
Showing 1 - 4 of 4
Cover Image
The Authors’ Reply
Bagust, Adrian; Evans, Marc; Beale, Sophie; Home, Philip; … - In: PharmacoEconomics 24 (2006) 9, pp. 929-935
Persistent link: https://www.econbiz.de/10010848969
Cover Image
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
Moore, Lee; Remy, Vanessa; Martin, Monique; Beillat, Maud; … - London School of Economics (LSE) - 2010
Persistent link: https://www.econbiz.de/10010884529
Cover Image
Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany
Shearer, Arran; Bagust, Adrian; Liebl, Andreas; … - In: PharmacoEconomics 24 (2006) 1, pp. 35-48
<Emphasis Type="Bold">Aims/hypothesis: To assess the cost-effectiveness of rosiglitazone in combination with other oral agents for the treatment of overweight and obese patients with type 2 diabetes in Germany. <Emphasis Type="Bold">Methods: The Diabetes Decision Analysis of Cost — type 2 model was adapted for clinical practice and...</emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011001521
Cover Image
The Authors' Reply
Bagust, Adrian A.; Evans, Marc; Beale, Sophie; Home, Philip - In: PharmacoEconomics 24 (2006) 9, pp. 929-935
Persistent link: https://www.econbiz.de/10005449037